Navigation Links
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Date:3/12/2009

exposed to a very potent stimulant (TRAP-thrombin receptor agonist peptide)," said Enrico Veltri, M.D., group vice president of global clinical research, cardiovascular and metabolic disease, Schering-Plough Research Institute. "These data, along with subsequent data from Phase II acute coronary syndromes (ACS) and stroke studies conducted in Japan, suggest that TRA is a novel medication that targets a pathway to platelet aggregation not addressed by existing medications."

The 1,030-patient TRA-PCI trial was designed to evaluate the safety and tolerability of TRA in patients undergoing PCI. A secondary objective was to assess whether patients treated with the compound in addition to standard-of-care therapies had fewer cardiovascular events such as heart attack, need for urgent coronary revascularization, or death at 60 days compared to patients treated with the standard of care alone. While not powered to establish efficacy, the study did report a non-statistically significant 46 percent reduction in cardiovascular events at the highest TRA dose tested compared to standard of care alone. Preliminary results were presented in March 2007 at the American College of Cardiology/i2 Summit in New Orleans by David J. Moliterno, M.D., Chief of Cardiovascular Medicine, University of Kentucky College of Medicine, and Medical Director of the Linda and Jack Gill Heart Institute, on behalf of the TRA-PCI investigators.

Study Design

The Phase II TRA-PCI trial was a multinational, randomized, double-blind, placebo-controlled dose-ranging trial assessing both oral loading doses as well as maintenance doses of Schering-Plough's TRA. The trial enrolled 1,030 patients 45 years or older, with coronary artery disease for whom PCI was planned, and randomized to one of three oral loading doses of TRA (10mg, 20mg or 40mg) or placebo in a 3:1 ratio of active drug to placebo. The loading doses were increased in a sequential fas
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
2. Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
3. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
4. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
7. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
8. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
11. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015  Protiviti, a global consulting firm, today announced ... the World publication ( www.protiviti.com/iaworld ). For more ... the evolution of the internal audit profession through the ... a means to providing senior executives and internal audit ... function. The 2015 edition of Internal ...
(Date:7/6/2015)... 6, 2015 E-QURE Corp (OTCQB: EQUR), today ... at VirtualInvestorConferences.com on July 9, 2015. DATE: Thursday, ... This will be a live, ... the company questions in real-time - both in the ... booth." If attendees are not able to join the ...
(Date:7/6/2015)... 6, 2015 Array BioPharma,s (NASDAQ:   ... past weekend at the 2015 ESMO World Congress ... the meeting, data were shared from a Phase ... randomized Phase 2 expansion of that trial testing ... inhibitor, with or without the addition of alpelisib ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... 2011 NxStage Medical, Inc. (Nasdaq: NXTM ... announced that Jeffrey H. Burbank, CEO, received the Ernst ... New England Award in the Medical Devices category. The ... success in such areas as innovation, financial performance and ...
... ADDISON, Texas, June 17, 2011 ULURU Inc. (NYSE ... Stockholders was reconvened on June 16, 2011 for the purpose of ... to authorize the Board of Directors to amend the Company,s Restated ... to effect a reverse stock split of the Company,s outstanding common ...
Cached Medicine Technology:NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 2NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 3NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 4ULURU Inc. Announces Voting Results of Reconvened Annual Meeting of Stockholders 2
(Date:7/6/2015)... ... July 06, 2015 , ... “ TapGlance ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... this interior design app helps users visualize what rooms will look like before they ...
(Date:7/6/2015)... ... 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female Hair Loss ... age 35 a quarter of all women in the U.S. will suffer from thinning hair ... and rarely discussed. One woman, a former beauty queen, who was interviewed for the report ...
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to Cover: , ... is a large gap between the unmet health priorities in the region and ... and reduce unnecessary or ineffective treatments or procedures. , This milestone conference, sponsored ...
(Date:7/6/2015)... BC (PRWEB) , ... July 06, 2015 , ... Olive ... received the UBC 2014-2015 Post Graduate Teaching Award on behalf of the department of ... is a very exciting field to be practicing in. The technology is changing so ...
(Date:7/6/2015)... Irvine, CA (PRWEB) , ... July 06, 2015 ... ... for disease prevention in southern California, has partnered with Woodbridge Walk-In Urgent Care ... disease, cancer, stroke and other serious medical conditions. Screenings are affordable and accurate ...
Breaking Medicine News(10 mins):Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2
... Home, Assisted Living, Home Care and Adult Day Health Care ... Long term care costs in Alaska remain the highest ... in or near retirement, according to an annual study by ... downturn has led to a decline in home values and ...
... Assisted Living, Home Care and Adult Day Health Care Costs ... The cost of long term care in Oklahoma is rising ... those in or near retirement, according to an annual study ... economic downturn has led to a decline in home values ...
... Access to Nursing Home, Assisted Living, Home Care and Adult ... Va., April 30 /PRNewswire/ -- The ... a rate outpacing inflation, putting significant financial pressure on those ... Genworth Financial. At the same time, the current economic ...
... Residents Access to Nursing Home, Assisted Living, Home Care ... Code Statewide RICHMOND, Va., April 30 The cost of ... outpacing inflation, putting significant financial pressure on those in or ... At the same time, the current economic downturn has ...
... Nursing Home, Assisted Living, Home Care and Adult Day Health ... 30 The cost of long term care in Hawaii ... pressure on those in or near retirement, according to an ... the current economic downturn has led to a decline in ...
... JAG Media Holdings, Inc. (OTC Bulletin Board: JAGH) ... proposed acquisition of CardioGenics Inc. by a to-be-created Canadian ... into a Letter of Intent on March 12, 2009. ... such as the preparation and negotiation of the required ...
Cached Medicine News:Health News:Alaska Long Term Care Costs Highest in the Nation, Although Growth in Costs Trails National Average, According to Annual Genworth Financial Study 2Health News:Alaska Long Term Care Costs Highest in the Nation, Although Growth in Costs Trails National Average, According to Annual Genworth Financial Study 3Health News:Alaska Long Term Care Costs Highest in the Nation, Although Growth in Costs Trails National Average, According to Annual Genworth Financial Study 4Health News:Growth of Long Term Care Costs Outpacing the Rate of Inflation in Oklahoma, According to Annual Genworth Financial Study 2Health News:Growth of Long Term Care Costs Outpacing the Rate of Inflation in Oklahoma, According to Annual Genworth Financial Study 3Health News:Growth of Long Term Care Costs Outpacing the Rate of Inflation in Oklahoma, According to Annual Genworth Financial Study 4Health News:Growth in Kentucky Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Kentucky Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Kentucky Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Indiana Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Indiana Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Indiana Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Hawaii Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Hawaii Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Hawaii Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:JAG Media Holdings, Inc. Announces Update of the Status of its Proposed Acquisition of CardioGenics Inc. 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: